Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
NBIX:NASDAQ
Neurocrine Biosciences Inc
US$ 128.04
+0.28%
(+0.36) Siku 1
US$ 128.04
0.00% (0.00)
Baada ya saa
Imefungwa: 27 Apr, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya NBIX...
Fungua
US$ 127.43
Juu
US$ 129.46
Chini
US$ 126.99
Mtaji wa soko
12.88B
Wastani wa kiasi cha mauzo
1.08M
Kiasi cha mauzo ya hisa
222.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
27.42
Juu kwa wiki 52
US$ 160.18
Chini kwa wiki 52
US$ 101.15
EPS
US$ 4.67
Beta
0.35
Hisa za wawekezaji
100.36M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia. The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Kuhusu Neurocrine Biosciences Inc
Afisa Mkuu Mtendaji (CEO)Kevin C. Gorman
Wafanyakazielfu 2
Lilianzishwa1992
Makao makuuSan Diego, California, Marekani
Sekta-
Tovutineurocrine.com
Simu inayofuata baada ya siku baada ya siku 7
Jumanne, 5 Mei, 16:30
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
-/ (1.71 inakadiriwa)USD
Mapato au Kadirio
-/ (771.20M inakadiriwa)USD
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari: mapato yajayoMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
572.60M
687.50M
794.90M
805.50M
Gharama ya bidhaa zilizouzwa
272.40M
255.60M
264.00M
275.80M
Gharama ya mapato
272.40M
255.60M
264.00M
275.80M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
276.50M
286.30M
291.60M
302.50M
Gharama ya uendeshaji
276.50M
286.30M
291.60M
302.50M
Jumla ya gharama za uendeshaji
548.90M
541.90M
555.60M
578.30M
Mapato ya uendeshaji
23.70M
145.60M
239.30M
227.20M
Mapato mengine yasiyo ya uendeshaji
-
-
-
-
EBT ikijumuisha vipengee visivyo vya kawaida
14.70M
159.50M
291.80M
239.40M
EBT bila kujumuisha vipengee visivyo vya kawaida
45.40M
166.20M
261.50M
253.00M
Gharama ya kodi ya mapato
6.80M
52.00M
82.30M
85.70M
Kiwango cha kodi kinachotumika
46.26%
32.60%
28.20%
35.80%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
7.90M
107.50M
209.50M
153.70M
Kiwango cha faida halisi
1.38%
15.64%
26.36%
19.08%
Mapato kwa kila hisa
0.70
1.65
2.17
1.88
Mapato ya riba na uwekezaji
21.70M
20.60M
22.20M
25.80M
Gharama ya riba
-
-
-
-
Jumla ya gharama halisi za riba
21.70M
20.60M
22.20M
25.80M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
31.30M
152.90M
247.00M
234.70M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho